ロード中...
Evaluating Change in Disease Activity Needed to Reflect Meaningful Improvement in Quality of Life for Clinical Trials in Cutaneous Lupus Erythematosus
BACKGROUND: Outcome measures of clinical trials in cutaneous lupus erythematosus (CLE) should reflect clinically meaningful improvement in disease activity, as measured by the Cutaneous Lupus Disease Area and Severity Index activity score (CLASI-A). OBJECTIVE: We aim to define the degree of improvem...
保存先:
| 出版年: | J Am Acad Dermatol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8106875/ https://ncbi.nlm.nih.gov/pubmed/32682879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.07.047 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|